Publication

Maggert KA. 2019. Stress: An evolutionary mutagen. Proc Natl Acad Sci U S A. 116:17616–17618. doi:10.1073/pnas.1912725116.

Aryanpur PP, Renner DM, Rodela E, Mittelmeier TM, Byrd A, Bolger TA. 2019. The DEAD-box RNA helicase Ded1 has a role in the translational response to TORC1 inhibition. Mol Biol Cell. 30:2171–2184. doi:10.1091/mbc.E18-11-0702.

Smith TT, Donny EC, Luo X, Allen AM, Carroll DM, Denlinger-Apte RL, Dermody SS, Koopmeiners JS, McClernon FJ, Pacek LR, et al. 2019. The Impact of Gradual and Immediate Nicotine Reduction on Subjective Cigarette Ratings. Nicotine Tob Res. 21:S73-S80. doi:10.1093/ntr/ntz158.

Bughio F, Maggert KA. 2019. The peculiar genetics of the ribosomal DNA blurs the boundaries of transgenerational epigenetic inheritance. Chromosome Res. 27:19–30. doi:10.1007/s10577-018-9591-2.

Ji J, Tang X, Hu W, Maggert KA, Rong YS. 2019. The processivity factor Pol32 mediates nuclear localization of DNA polymerase delta and prevents chromosomal fragile site formation in Drosophila development. PLoS Genet. 15:e1008169. doi:10.1371/journal.pgen.1008169.

Danilov SM, Metzger R, Klieser E, Sotlar K, Trakht IN, Garcia JGN. 2019. Tissue ACE phenotyping in lung cancer. PLoS One. 14:e0226553. doi:10.1371/journal.pone.0226553.

Gartrell RD, Marks DK, Rizk EM, Bogardus M, Gérard CL, Barker LW, Fu Y, Esancy CL, Li G, Ji J, et al. 2019. Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma. Clin Cancer Res. 25:2494–2502. doi:10.1158/1078-0432.CCR-18-2847.

Kannaiyan R, Mahadevan D. 2018. A comprehensive review of protein kinase inhibitors for cancer therapy. Expert Rev Anticancer Ther. 18:1249–1270. doi:10.1080/14737140.2018.1527688.

Teknos TN, Grecula J, Agrawal A, Old MO, Ozer E, Carrau R, Kang S, Rocco J, Blakaj D, Diavolitsis V, et al. 2018 Dec. A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma. Invest New Drugs. doi:10.1007/s10637-018-0696-4.

Loescher LJ, Howerter AL, Heslin KM, Azzolina CM, Muramoto ML. 2018. A Survey of Licensed Massage Therapists’ Perceptions of Skin Cancer Prevention and Detection Activities. Int J Ther Massage Bodywork. 11:4–10.

Mandava S, Keerthivasan MB, Li Z, Martin DR, Altbach MI, Bilgin A. 2018. Accelerated MR parameter mapping with a union of local subspaces constraint. Magn Reson Med. 80:2744–2758. doi:10.1002/mrm.27344.

Shelar S, Shim E-H, Brinkley GJ, Kundu A, Carobbio F, Poston T, Tan J, Parekh V, Benson D, Crossman DK, et al. 2018. Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer. Clinical Cancer Research. 24(24):6433–6446.

Keener JE, Zambrano DE, Zhang G, Zak CK, Reid DJ, Deodhar BS, Pemberton JE, Prell JS, Marty MT. 2018 Dec. Chemical additives enable native mass spectrometry measurement of membrane protein oligomeric state within intact nanodiscs. J Am Chem Soc. doi:10.1021/jacs.8b11529.

Madan N, Abdelrazek H, Patil PD, Ross MD, Roy SB, Thawani N, Hahn MF, Bremner RM, Panchabhai TS. 2018. Development of Squamous Cell Carcinoma After Pulmonary Aspergillosis in the Native Lung of a Lung Transplant Recipient: A Case Report. Transplant Proc. 50:4080–4084. doi:10.1016/j.transproceed.2018.07.034.

Chakrabarti J, Holokai L, Syu L, Steele NG, Chang J, Wang J, Ahmed S, Dlugosz A, Zavros Y. 2018. Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer. Oncotarget. 9:37439–37457. doi:10.18632/oncotarget.26473.

Song JH, Singh N, Luevano LA, Padi SKR, Okumura K, Olive V, Black SM, Warfel NA, Goodrich DW, Kraft AS. 2018. Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase. Mol Cancer Ther. 17:2710–2721. doi:10.1158/1535-7163.MCT-18-0374.

Kelly KR, Friedberg JW, Park SI, McDonagh K, Hayslip J, Persky D, Ruan J, Puvvada S, Rosen P, Iyer SP, et al. 2018. Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma. Clin Cancer Res. 24:6150–6159. doi:10.1158/1078-0432.CCR-18-0286.

Eshghi N, Garland LL, Choudhary G, Hsu CC, Eshghi A, Han J, Hamilton RJ, Krupinski E, Kuo PH. 2018. Regional Changes in Brain F-FDG Uptake After Prophylactic Cranial Irradiation and Chemotherapy in Small Cell Lung Cancer May Reflect Functional Changes. J Nucl Med Technol. 46:355–358. doi:10.2967/jnmt.118.212316.

Abraham I, Curiel-Lewandrowski C. 2018. Staging Systems to Predict Metastatic Cutaneous Squamous Cell Carcinoma: Unsatisfactory for Clinical Use, but Some Less So? JAMA Dermatol. 154:1391–1392. doi:10.1001/jamadermatol.2018.3940.

Kerins MJ, Ooi A. 2018. The Roles of NRF2 in Modulating Cellular Iron Homeostasis. Antioxid Redox Signal. 29:1756–1773. doi:10.1089/ars.2017.7176.

Peyton CC, Chipollini J, Azizi M, Kamat AM, Gilbert SM, Spiess PE. 2018 Dec. Updates on the use of intravesical therapies for non-muscle invasive bladder cancer: how, when and what. World J Urol. doi:10.1007/s00345-018-2591-1.

Boese CJ, Nye J, Buster DW, McLamarrah TA, Byrnes AE, Slep KC, Rusan NM, Rogers GC. 2018. Asterless is a Polo-like kinase 4 substrate that both activates and inhibits kinase activity depending on its phosphorylation state. Mol Biol Cell. 29:2874–2886. doi:10.1091/mbc.E18-07-0445.

Song B, Sunny S, Uthoff RD, Patrick S, Suresh A, Kolur T, Keerthi G, Anbarani A, Wilder-Smith P, Kuriakose MA, et al. 2018. Automatic classification of dual-modalilty, smartphone-based oral dysplasia and malignancy images using deep learning. Biomed Opt Express. 9:5318–5329. doi:10.1364/BOE.9.005318.

Oh M, McBride A, Yun S, Bhattacharjee S, Slack M, Martin JR, Jeter J, Abraham I. 2018. BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis. J Natl Cancer Inst. 110:1178–1189. doi:10.1093/jnci/djy148.

Peyton CC, Tang D, Reich RR, Azizi M, Chipollini J, Pow-Sang JM, Manley B, Spiess PE, Poch MA, Sexton WJ, et al. 2018. Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder Cancer. JAMA Oncol. 4:1535–1542. doi:10.1001/jamaoncol.2018.3542.